BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 17268034)

  • 1. Stunning effect.
    Gerard SK; Park HM
    J Nucl Med; 2007 Feb; 48(2):328-9; author reply 329-30. PubMed ID: 17268034
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyroid stunning.
    Medvedec M
    J Nucl Med; 2001 Jul; 42(7):1129-31. PubMed ID: 11438638
    [No Abstract]   [Full Text] [Related]  

  • 3. Stunning after tracer dosimetry.
    Diehl M; Grünwald F
    J Nucl Med; 2001 Jul; 42(7):1129. PubMed ID: 11438639
    [No Abstract]   [Full Text] [Related]  

  • 4. Thyroid stunning in clinical practice: is it a real problem?
    Filesi M; Colandrea M; Montesano T; D'Apollo R; Ronga G
    Minerva Endocrinol; 2009 Mar; 34(1):29-36. PubMed ID: 19209126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110 MBq (30 mCi) and 3700 MBq (100 mCi) post-surgical 131I ablation therapy for differentiated thyroid carcinoma.
    Cherk MH; Kalff V; Yap KS; Bailey M; Topliss D; Kelly MJ
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):957-62. PubMed ID: 18419785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary on article by Rudavsky and Freeman.
    Lukinac L; Franceschi D; Kusic Z
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4277. PubMed ID: 9398757
    [No Abstract]   [Full Text] [Related]  

  • 7. Thyroid stunning.
    Coakley AJ
    Eur J Nucl Med; 1998 Mar; 25(3):203-4. PubMed ID: 9580850
    [No Abstract]   [Full Text] [Related]  

  • 8. Procedure guideline for therapy of thyroid disease with (131)iodine.
    Meier DA; Brill DR; Becker DV; Clarke SE; Silberstein EB; Royal HD; Balon HR;
    J Nucl Med; 2002 Jun; 43(6):856-61. PubMed ID: 12050333
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term recurrence of thyroid cancer after thyroid remnant ablation with 1.1 and 3.7 GBq radioiodine.
    Rosário PW; Purisch S; Vasconcelos FP; Padrão EL; Rezende LL; Barroso AL
    Nucl Med Commun; 2007 Jun; 28(6):507-8. PubMed ID: 17460543
    [No Abstract]   [Full Text] [Related]  

  • 10. The carcinogenic effects of radioiodine therapy for thyroid carcinoma.
    de Vathaire F
    Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):180-1. PubMed ID: 18283326
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-iodine diet in the treatment of differentiated thyroid cancer with radioactive iodine.
    Sonenberg M
    Endocrine; 2002 Mar; 17(2):141-3. PubMed ID: 12041916
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiation-induced thyroid stunning: differential effects of (123)I, (131)I, (99m)Tc, and (211)At on iodide transport and NIS mRNA expression in cultured thyroid cells.
    Lundh C; Lindencrona U; Postgård P; Carlsson T; Nilsson M; Forssell-Aronsson E
    J Nucl Med; 2009 Jul; 50(7):1161-7. PubMed ID: 19525464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Online regulatory guide errors.
    Dawry FP
    J Nucl Med; 2002 Feb; 43(2):284. PubMed ID: 11858234
    [No Abstract]   [Full Text] [Related]  

  • 14. Iodine-refractory differentiated thyroid cancer: an ominous diagnosis with the potential for a brighter future.
    Sipos JA; Kloos RT
    Clin Adv Hematol Oncol; 2008 Oct; 6(10):767-9. PubMed ID: 18997668
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute myeloid leukemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseases.
    Focosi D; Galimberti S; Petrini M
    Haematologica; 2007 Sep; 92(9):e96-7. PubMed ID: 17768141
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation between external exposure and activity in patients undergoing 131I thyroid cancer therapy.
    Barquero R; Basurto F; Vega-Carrillo HR; Iñiguez MP; Ferrer N; Esteban R
    Health Phys; 2008 Aug; 95(2):227-33. PubMed ID: 18617804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of radiation absorbed doses to nodal metastases.
    Koral KF; Adler RS
    J Nucl Med; 1993 Mar; 34(3):524-6. PubMed ID: 8441051
    [No Abstract]   [Full Text] [Related]  

  • 18. 131I radiation dose distribution in metastases of thyroid carcinoma.
    Eterovic D; Markovic V; Punda A; Antunovic Z
    J Nucl Med; 2009 May; 50(5):833-4; author reply 834. PubMed ID: 19372490
    [No Abstract]   [Full Text] [Related]  

  • 19. Radioiodine in the treatment of thyroid cancer.
    Van Nostrand D; Wartofsky L
    Endocrinol Metab Clin North Am; 2007 Sep; 36(3):807-22, vii-viii. PubMed ID: 17673129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of pregnancy in women with thyroid carcinoma.
    Schlumberger M; De Vathaire F; Ceccarelli C; Francese C; Pinchera A; Parmentier C
    J Endocrinol Invest; 1995 Feb; 18(2):150-1. PubMed ID: 7629385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.